Get help now — free helplines

You can call any of these for free. You do not need a diagnosis, an appointment, or a crisis to call — questions and plain exhaustion are reasons enough.

  • Alzheimer's Association 24/7 Helpline 800-272-3900 24 hours a day, 365 days a year Free, confidential support and information for people with dementia, caregivers, families and the public. Master's-level clinicians. Also Spanish.
  • 988 Suicide & Crisis Lifeline 988 24/7 Call or text 988, or chat at 988lifeline.org. For anyone in emotional distress or a mental-health crisis, including caregivers.
  • Alzheimer's Foundation of America (AFA) Helpline 866-232-8484 9:00 am - 9:00 pm ET, seven days a week Licensed social workers providing support, info and referrals. Also text message and web chat. Text: 646-586-5283

In a medical emergency, call 911. More numbers, and what each line does, on the help page.

What "newest" means here

The most recent study in this library is dated 2026-11-01 (Paths of Aging Minds: Health Journeys of Older Adults with Mild Cognitive Impairment). This is our summary library, not a news wire — it is added to in batches, so the newest entry may not be the newest paper published anywhere.

Entries are sorted strictly by publication date, newest first. 26489 of the 27380 entries carry a full day-level date. 65 have no date recorded at all and are placed by publication year, at the start of that year; those are marked "no date recorded" below so you can see where the ordering is a best effort rather than a fact.

Prefer a reader? Subscribe to the Atom feed. Want them sorted by subject or by score instead? Browse the research library.

Showing 21,401–21,425 of 27,380 studies, newest first · page 857 of 1096.

June 2009 25

  1. 2009-06-26

    Statin‐Associated Adverse Cognitive Effects: Survey Results from 171 Patients

    ✓ Peer-reviewed Drug development Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy

    Key finding: Patients completed a survey assessing statin-associated, cognitive-specific adverse drug reaction (ADR) characteristics, relation of the ADR to specific statin and dose (or potency), and time course of symptom onset and recovery. +4 more findings

  2. 2009-06-26

    Treatment with a C5aR antagonist decreases pathology and enhances behavioral performance in murine models of Alzheimer's disease

    ✓ Peer-reviewed Inflammation and the immune system Journal of immunology (Baltimore, Md. : 1950)

    Key finding: Components of the complement system, known to produce a local inflammatory reaction, are associated with the plaques and tangles in AD brain, and thus a role for complement-mediated inflammation in the acceleration or progression of disease has been proposed. +3 more findings

  3. 2009-06-24

    Role of synucleins in Alzheimer's disease

    ✓ Peer-reviewed Disease mechanisms Neurotoxicity research

    Key finding: Most of the studies in AD have been focused on investigating the role of Abeta and Tau; however, recent studies suggest that alpha-syn might also play a role in the pathogenesis of AD. +1 more finding

  4. 2009-06-23

    Regulation of mitochondrial respiratory chain biogenesis by estrogens/estrogen receptors and physiological, pathological and pharmacological implications

    ✓ Peer-reviewed Brain scans and imaging Biochimica et biophysica acta

    Key finding: There has been increasing evidence pointing to the mitochondrial respiratory chain (MRC) as a novel and important target for the actions of 17beta-estradiol (E(2)) and estrogen receptors (ER) in a number of cell types and tissues that have high demands for mitochondrial energy metabolism. +3 more findings

  5. 2009-06-21

    β-Amyloid impairs axonal BDNF retrograde trafficking

    ✓ Peer-reviewed Disease mechanisms Neurobiology of aging

    Key finding: Alzheimer disease (AD) is characterized by early impairments in synaptic function that may result in part from neurotrophin signaling deficits. +1 more finding

  6. 2009-06-19
  7. 2009-06-19

    Differential processing of amyloid-beta precursor protein directs human embryonic stem cell proliferation and differentiation into neuronal precursor cells

    ✓ Peer-reviewed Down syndrome and Alzheimer's The Journal of biological chemistry

    Key finding: We recently reported that this protein, normally associated with neurodegenerative conditions, is expressed by human embryonic stem cells (hESCs). +2 more findings

  8. 2009-06-18

    Functional amyloids as natural storage of peptide hormones in pituitary secretory granules

    ✓ Peer-reviewed Risk factors Science (New York, N.Y.)

    Key finding: Amyloids are highly organized cross-beta-sheet-rich protein or peptide aggregates that are associated with pathological conditions including Alzheimer's disease and type II diabetes. +2 more findings

  9. 2009-06-15

    Lithium Trial in Alzheimer's Disease

    ✓ Peer-reviewed Drug development The Journal of Clinical Psychiatry

    Key finding: No treatment effect on GSK-3 activity or CSF-based biomarker concentrations (P >. 05) was observed. +3 more findings

  10. 2009-06-15

    Cognitive function in early Parkinson's disease: a population-based study

    ✓ Peer-reviewed Digital health tools European journal of neurology

    Key finding: Cognitive dysfunction is common in untreated patients in early PD, affecting attention, psychomotor function, episodic memory, executive function and category fluency. +3 more findings

  11. 2009-06-14

    Recommendations on the diagnosis and management of Niemann-Pick disease type C

    ✓ Peer-reviewed Clinical safety Molecular genetics and metabolism

    Key finding: In most countries, NP-C is managed through specialist centers, with non-specialist support provided locally. +4 more findings

  12. 2009-06-13

    Molecular genetic analysis of Down syndrome

    ✓ Peer-reviewed Down syndrome and Alzheimer's Human genetics

    Key finding: Down syndrome (DS) is caused by trisomy of all or part of human chromosome 21 (HSA21) and is the most common genetic cause of significant intellectual disability. +2 more findings

  13. 2009-06-12
  14. 2009-06-12

    Prevalence of depression among older Americans: the Aging, Demographics and Memory Study

    ✓ Peer-reviewed Disparities International psychogeriatrics

    Key finding: The finding of similar prevalence estimates for depression in men and women was not consistent with prior research that has shown a female predominance. +2 more findings

  15. 2009-06-12

    Omega-3 fatty acids and dementia

    ✓ Peer-reviewed Prevention and risk Prostaglandins, leukotrienes, and essential fatty acids

    Key finding: More than a dozen epidemiological studies have reported that reduced levels or intake of omega-3 fatty acids or fish consumption is associated with increased risk for age-related cognitive decline or dementia such as Alzheimer's disease (AD). +2 more findings

  16. 2009-06-10

    Memantine in patients with Parkinson's disease dementia or dementia with Lewy bodies: a double-blind, placebo-controlled, multicentre trial

    ✓ Peer-reviewed Treatments The Lancet. Neurology

    Key finding: 72 patients with PDD or DLB were randomly assigned and started treatment: 34 with memantine and 38 with placebo. 56 (78%) completed the study. +1 more finding

  17. 2009-06-10

    Dystrophic (senescent) rather than activated microglial cells are associated with tau pathology and likely precede neurodegeneration in Alzheimer's disease

    ✓ Peer-reviewed Inflammation and the immune system Acta neuropathologica

    Key finding: Although several works suggest that chronic neuroinflammation caused by activated microglia contributes to neurofibrillary degeneration, anti-inflammatory drugs do not prevent or reverse neuronal tau pathology. +3 more findings

  18. 2009-06-10

    Soluble fibrillar oligomer levels are elevated in Alzheimer's disease brain and correlate with cognitive dysfunction

    ✓ Peer-reviewed Cognitive tests and assessment Neurobiology of disease

    Key finding: Fibrillar plaque deposits are present in non-demented individuals and levels of soluble Abeta correlate better with cognitive dysfunction in AD and transgenic mouse models. +3 more findings

  19. 2009-06-10

    Prevalence of functional disability in activities of daily living (ADL), instrumental activities of daily living (IADL) and associated factors, as predictors of morbidity and mortality

    ✓ Peer-reviewed How common it is Archives of gerontology and geriatrics

    Key finding: There is a significant association between age, gender and dependence, as well as between dependence and morbidity and mortality, so that dependence could be used as a predictor of both.

  20. 2009-06-10

    Prevalence and prognostic value of CSF markers of Alzheimer's disease pathology in patients with subjective cognitive impairment or mild cognitive impairment in the DESCRIPA study: a prospective cohort study

    ✓ Peer-reviewed How common it is The Lancet. Neurology

    Key finding: The CSF AD profile was more common in patients with SCI (31 of 60 [52%]), naMCI (25 of 37 [68%]), and aMCI (56 of 71 [79%]) than in healthy controls (28 of 89 [31%]). +2 more findings

  21. 2009-06-09

    The cognitive impact of anticholinergics: a clinical review

    ✓ Peer-reviewed Clinical safety Clinical interventions in aging

    Key finding: Medications with anticholinergic activity negatively affect the cognitive performance of older adults.

  22. 2009-06-09
  23. 2009-06-09

    Neurons in the white matter of the adult human neocortex

    ✓ Peer-reviewed Brain scans and imaging Frontiers in neuroanatomy

    Key finding: Interstitial neurons are most prominent in human brain, and only rudimentary in the brain of non-primate mammals. +4 more findings

  24. 2009-06-07

    Transmission and spreading of tauopathy in transgenic mouse brain

    ✓ Peer-reviewed Lewy body dementia Nature cell biology

    Key finding: Tau mutations cause familial forms of frontotemporal dementia, establishing that tau protein dysfunction is sufficient to cause neurodegeneration and dementia. +4 more findings

  25. 2009-06-06

    Automated MRI-based classification of primary progressive aphasia variants

    ✓ Peer-reviewed Digital health tools NeuroImage

    Key finding: Degeneration of language regions in the dominant hemisphere can result in primary progressive aphasia (PPA), a clinical syndrome characterized by progressive deficits in speech and/or language function. +3 more findings

Browse the library by subject, with the full score breakdown →